TNON Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
1.3M
-7.3%
1.4M
-6.9%
1.5M
+26.3%
1.2M
+108.0%
564.0K
Cost of Revenue
465.0K
+7.1%
434.0K
-6.5%
464.0K
+16.0%
400.0K
+25.4%
319.0K
Gross Profit
814.0K
-13.9%
945.0K
-7.1%
1.0M
+31.6%
773.0K
+215.5%
245.0K
Operating Expenses
4.2M
-1.3%
4.2M
+8.8%
3.9M
-6.8%
4.2M
+34.3%
3.1M
R&D
768.0K
+16.0%
662.0K
+25.6%
527.0K
+23.1%
428.0K
-14.9%
503.0K
SG&A
3.4M
-4.6%
3.6M
+6.2%
3.4M
-10.2%
3.7M
+43.8%
2.6M
Operating Income
-3354000
-2.3%
-3280000
-14.4%
-2866000
+15.5%
-3392000
-18.7%
-2857000
EBITDA
-3294000
-3.2%
-3192000
-15.2%
-2771000
+16.4%
-3315000
-18.0%
-2809000
Net Income
-4050000
-16.5%
-3476000
-22.7%
-2832000
+15.2%
-3339000
-20.6%
-2769000
EPS (Basic)
$-12.35
-13.8%
$-10.85
-91.4%
$-5.67
+59.5%
$-14.00
-9.7%
$-12.76
EPS (Diluted)
$-12.35
-13.8%
$-10.85
-91.4%
$-5.67
+59.5%
$-14.00
-9.7%
$-12.76
Shares (Diluted)
328.0K
+1.9%
321.9K
-35.5%
499.2K
+111.8%
235.7K
+8.6%
217.0K
Tenon Medical (TNON) โ€” Financials